Company: ARTL
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0001640334-25-000335
Chunk: 557

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-03-03
Form: 10-K
Item: Item 2
Chunk 557
---
wards  Awards  Compensation  Compensation  Compensation  Total Name ($)   ($)  ($)(1)  ($)  Earnings ($)  ($)  ($)                       Connie Matsui(3)  76,500   -   12,005(2)  -   -   -   88,505 Douglas Blayney, M.D.(4)  48,000   -   10,452(2)  -   -   -   58,452 Gregory R. Reyes, M.D., Ph.D.(5)  45,000   -   5,630(2)  -   -   -   50,630 R. Martin Emanuele, Ph.D.(6)  44,000   -   10,136(2)  -   -   -   54,136 Steven Kelly(7)  59,500   -   10,956(2)  -   -   -   70,456 Tamara A. Favorito(8)  60,000   -   3,251(2)  -   -   -   63,251 

(1)In accordance with SEC rules, the amounts shown reflect the aggregate grant date fair value of stock awards granted to Non-Employee Directors during 2024, computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718 (“FASB ASC 718”). The grant date fair value for stock options is measured based on the Black-Scholes Model. See Note 5 – Equity to our audited financial statements included in this Annual Report on Form 10-K:(2)On February 28, 2024, previously issued options were repriced to $1.55 and had their vesting schedules modified.  As per ASC 718 the changes were treated as modifications to the options.(3)17,235 option awards outstanding as of December 31, 2024.(4)15,334 option awards outstanding as of December 31, 2024.(5)12,834 option awards outstanding as of December 31, 2024.(6)14,869 option awards outstanding as of December